Delhi HC refuses patent for Nematode-based cancer detection method

Hirotsu Bio Science Inc. contended that its method only indicated cancer risk and did not involve medical judgment or clinical decision-making. However, the Court found that the method involved all essential steps of a diagnostic process, including data collection, comparison with standard values, and drawing conclusions indicative of disease presence.